Cargando…
SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer
Background: Prostate cancer is a major global challenge due to the increasing number of aging population and frequency of diagnosis. During the past decade new treatments have been targeted to the androgen signaling axis either by inhibiting the binding of androgens to androgen receptor (AR) and AR...
Autores principales: | Oksala, Riikka, Karimaa, Mari, Riikonen, Reetta, Räsänen, Kati, Ramela, Meri, Vehmaan-Kreula, Pirjo, Rummakko, Petteri, Wohlfahrt, Gerd, Mustonen, Mika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553147/ http://dx.doi.org/10.1210/js.2019-SUN-LB002 |
Ejemplares similares
-
SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies
por: Snaterse, Gido, et al.
Publicado: (2019) -
SAT-002 Measurement of Visceral Fat Using Computed Tomography in Two Subtypes of Primary Aldosteronism
por: Shibayama, Yui, et al.
Publicado: (2019) -
SUN-002 Control of Metastasis by DAX-1 in Prostate Cancer Cells, an Androgen-Induced Orphan Nuclear Receptor
por: Beltran, Roxxana, et al.
Publicado: (2019) -
SAT-LB004 Therapeutic Potential of LPCN 1144 in NAFLD and NASH
por: Baker, Jonathan, et al.
Publicado: (2019) -
SUN-LB138 Dynamic Structural Model of Testosterone Entry Into the Unliganded Androgen Receptor
por: Krylova, Irina, et al.
Publicado: (2020)